Development of a dissolvable microneedle influenza vaccine patch

dc.check.date10000-01-01
dc.check.embargoformatHard bound copy in Library onlyen
dc.check.infoRestricted to everyone for one yearen
dc.check.opt-outYesen
dc.check.reasonReleasing this thesis would cause substantial prejudice to the commercial interests of University College Corken
dc.check.typeNo Embargo Required
dc.contributor.advisorCrean, Abinaen
dc.contributor.advisorMoore, Anneen
dc.contributor.authorAllen, Evin A.
dc.contributor.funderCollege of Medicine and Health, University College Corken
dc.date.accessioned2016-08-12T10:39:26Z
dc.date.issued2016
dc.date.submitted2016
dc.description.abstractDelivery of large molecular weight biological molecules to the epidermis and dermis is constrained by the tough outer layer of the epidermis, the stratum corneum (sc). Microneedle technologies attempt to overcome this physical barrier using sharp micron-size projections to penetrate the sc. Dissolvable microneedles (DMN), are a particular microneedle design whereby the needle structure is composed of a soluble matrix that upon application to the skin, dissolves releasing the vaccine load into skin. This thesis examines (1) the formulation and processing considerations around DMN fabrication, (2) the immunogenicity of DMN containing trivalent influenza vaccine (TIV) in pre-clinical mouse and pig models and (3) the thermostability of these DMN formulations during storage. The results demonstrate the importance of formulation for microneedle formation and mechanical strength. Trehalose and polyvinylalcohol based formulations produced optimal microneedle structures and were amenable to piezoelectric dispensing; allowing for precise multi-layered DMN to be fabricated. The effect of drying conditions was assessed and found to be critical for DMN mechanical strength and skin penetration. The antibody responses to TIV generated by DMN-mediated vaccination were comparable or greater to those induced by immunization with a commercial TIV via the IM route in mice. DMN mediated immunisation resulted in a significantly broader humoral response to heterotypic influenza viruses compared to IM delivery. Stored at 40°C, a licensed seasonal influenza vaccine incorporated into DMN array was thermostable for at least 6 month as determined by Single Radial Immunodiffusion and immunogenicity in mice. The thesis advances the field of DMN influenza vaccination by elucidating important processing and formulation considerations in the fabrication of highly reproducible DMN. It also demonstrated that DMN can induce broader, larger humoral responses than conventional IM administration while demonstrating enhanced accelerated stability. Crucially, this works advances an automated fabrication system that will allow for clinical translation of DMN.en
dc.description.statusNot peer revieweden
dc.description.versionAccepted Version
dc.format.mimetypeapplication/pdfen
dc.identifier.citationAllen, E. 2016. Development of a dissolvable microneedle influenza vaccine patch. PhD Thesis, University College Cork.en
dc.identifier.urihttps://hdl.handle.net/10468/2980
dc.language.isoenen
dc.publisherUniversity College Corken
dc.rights© 2016, Evin Allen.en
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/en
dc.subjectMicroneedlesen
dc.subjectVaccineen
dc.subjectInfluenzaen
dc.thesis.opt-outtrue
dc.titleDevelopment of a dissolvable microneedle influenza vaccine patchen
dc.typeDoctoral thesisen
dc.type.qualificationlevelDoctoralen
dc.type.qualificationnamePhD (Medicine and Health)en
Files
License bundle
Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
license.txt
Size:
5.62 KB
Format:
Item-specific license agreed upon to submission
Description:
Loading...
Thumbnail Image
Name:
Decision To Withold EThesis Summer 2016 Evin Allen.pdf
Size:
29.14 KB
Format:
Adobe Portable Document Format
Description:
Opt-out